Northstar Neuroscience to Present Clinical Trial Update during Conference Call on Tuesday October 10, 2006.SEATTLE -- Northstar Neuroscience, Inc. (Nasdaq: NSTR NSTR Nothing Significant To Report NSTR Naval Sea System Command Technical Representative ) announced today that it will discuss the status of three of its clinical trials investigating the use of Northstar's cortical cor·ti·cal adj. 1. Of, relating to, derived from, or consisting of cortex. 2. Of, relating to, associated with, or depending on the cerebral cortex. stimulation therapy system during a conference call scheduled for October 10, 2006. On the call, Northstar will provide updates for its EVEREST study in the treatment of hand/arm disability following stroke, its CHESTNUT study involving individuals with stroke-related Broca's aphasia Bro·ca's aphasia n. See motor aphasia. Broca's aphasia A condition characterized by either partial or total loss of the ability to express oneself, either through speech or writing. , and its study of cortical stimulation to treat severe tinnitus Tinnitus Definition Tinnitus is hearing ringing, buzzing, or other sounds without an external cause. Patients may experience tinnitus in one or both ears or in the head. . Management will host the conference call starting at 4:30 p.m. eastern time (1:30 p.m. pacific time), which will be concurrently web cast. The company plans to announce its financial results for the third quarter of 2006 in November. To listen to the conference call, please dial 1-800-659-1966 (US/Canada) or 1-617-614-2711 (International) and use the participant code "78098026" approximately ten minutes prior to the call start time. To access the live or archived audio broadcast and web cast, visit the investor relations Investor relations The process by which the corporation communicates with its investors. section of Northstar's web site at http://ir.northstarneuro.com. About Northstar Neuroscience Northstar Neuroscience, Inc. is a medical device company focused on developing and commercializing innovative neurostimulation therapies to restore function and quality of life for people suffering from stroke and other neurological diseases and disorders. Northstar's cortical stimulation therapy system is an investigational device that is in clinical trials for several indications, including stroke motor recovery, aphasia aphasia (əfā`zhə), language disturbance caused by a lesion of the brain, making an individual partially or totally impaired in his ability to speak, write, or comprehend the meaning of spoken or written words. , tinnitus and depression. For more information, visit www.northstarneuro.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion